Effect of raloxifene—a selective oestrogen receptor modulator—on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial
S. Hadjadj, P. Gourdy, P. Zaoui, B. Guerci, N. Roudaut, J. F. Gautier, M. Chabin, G. Mauco, S. Ragot, for the RADIAN (Raloxifene in Diabetic Nephropathy) Study GroupVolume:
24
Year:
2007
Language:
english
Pages:
5
DOI:
10.1111/j.1464-5491.2007.02165.x
File:
PDF, 155 KB
english, 2007